SAMANTHA ADERHOLDT: Open Payments
NPI 1477957736 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 29 payments from 13 companies in 2025. Trend: 2023 $1,578 · 2024 $2,106 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $164 |
| ABBVIE INC. | 6 | $109 |
| SANOFI-AVENTIS U.S. LLC | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: Wegovy, FARXIGA, VRAYLAR, AIRSUPRA, REXULTI, TZIELD, DALVANCE, Ozempic.
Industry payments across NJ — which companies pay providers there.
